Has the Ship Sailed on Second-Generation ALK Tyrosine Kinase Inhibitors in the Post-Crizotinib Setting? Ang YLE, Soo RA. J Thorac Oncol 2023;18:1621-1624.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ang YLE, Soo RA. Has the Ship Sailed on Second-Generation ALK Tyrosine Kinase Inhibitors in the Post-Crizotinib Setting? J Thorac Oncol 2023;18:1621-1624.
PMID: 37993214